{
    "2021-08-18": [
        [
            {
                "time": "2021-08-16",
                "original_text": "东吴证券维持安图生物买入评级：2021年中报业绩基本符合我们预期，看好公司化学发光成长与平台化业务拓展",
                "features": {
                    "keywords": [
                        "安图生物",
                        "化学发光",
                        "平台化",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-17",
                "original_text": "太平洋维持安图生物买入评级：新冠影响逐步减小，IVD平台化具备优势",
                "features": {
                    "keywords": [
                        "安图生物",
                        "新冠",
                        "IVD",
                        "平台化"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-18",
                "original_text": "简评爱博医疗、安图生物、公牛集团",
                "features": {
                    "keywords": [
                        "安图生物",
                        "爱博医疗",
                        "公牛集团"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "消费电子"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-19",
                "original_text": "安图生物(603658)：业务迅速恢复 多款新品推出成长动力十足",
                "features": {
                    "keywords": [
                        "安图生物",
                        "新品",
                        "业务恢复",
                        "成长动力"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-20",
                "original_text": "茅台创新低，一批牛股砸出深坑！大消费板块怎么了",
                "features": {
                    "keywords": [
                        "茅台",
                        "大消费",
                        "牛股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-21",
                "original_text": "安图生物(603658)半年报点评：Q2业绩进一步恢复 业务线向分子诊断拓展",
                "features": {
                    "keywords": [
                        "安图生物",
                        "Q2",
                        "分子诊断",
                        "业绩恢复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-22",
                "original_text": "安图生物上半年净利润增长51% 上海研发中心正式运营",
                "features": {
                    "keywords": [
                        "安图生物",
                        "净利润",
                        "上海研发中心"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "A股异动 | 安图生物(603658.SH)涨6% 上半年净利同比增50.63%",
                "features": {
                    "keywords": [
                        "安图生物",
                        "A股",
                        "净利增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "半年报解读|安图生物H1业绩增长五成 董秘：基本达到公司预期目标",
                "features": {
                    "keywords": [
                        "安图生物",
                        "半年报",
                        "业绩增长",
                        "董秘"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-25",
                "original_text": "安图生物(603658)：业绩符合预期 化学发光试剂恢复高增长趋势",
                "features": {
                    "keywords": [
                        "安图生物",
                        "化学发光",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}